Aspen Aerogels (NYSE:ASPN - Get Free Report) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of -0.180-0.000 for the period, compared to the consensus estimate of 0.080. The company issued revenue guidance of $75.0 million-$95.0 million, compared to the consensus revenue estimate of $104.2 million.
Analyst Ratings Changes
Several analysts recently weighed in on ASPN shares. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a report on Saturday, February 8th. Barclays reduced their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research report on Tuesday, November 12th. Canaccord Genuity Group decreased their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday. Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Finally, Craig Hallum decreased their target price on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research report on Friday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $24.67.
Check Out Our Latest Stock Analysis on Aspen Aerogels
Aspen Aerogels Stock Down 3.7 %
ASPN stock traded down $0.33 during trading on Friday, hitting $8.67. 5,245,173 shares of the stock traded hands, compared to its average volume of 1,390,847. The stock has a market cap of $711.05 million, a price-to-earnings ratio of 867.47 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a 1 year low of $8.25 and a 1 year high of $33.15. The firm's 50 day moving average is $12.17 and its two-hundred day moving average is $18.45.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. On average, sell-side analysts anticipate that Aspen Aerogels will post 0.12 EPS for the current year.
Aspen Aerogels Company Profile
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Read More

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.